Literature DB >> 151104

Radiotherapy of benign dermatoses: indications, practice, and results.

S Lukacs, O Braun-Falco, H Goldschmidt.   

Abstract

Limited indications for radiation treatment of benign dermatoses are presented in order to emphasize modern restrictions and techniques in the use of dermatologic radiation therapy and to promote measures of protection against stray radiation. The use of softer, less penetrating X rays, least effective doses and meticulous shielding are recommended. So done, radiation therapy offers an effective therapeutic alternative for conditions that do not respond to other forms of treatment.

Entities:  

Mesh:

Year:  1978        PMID: 151104     DOI: 10.1111/j.1524-4725.1978.tb00512.x

Source DB:  PubMed          Journal:  J Dermatol Surg Oncol        ISSN: 0148-0812


  4 in total

1.  [Radiotherapy in the early stage of Dupuytren's disease. The indications, technic and long-term results].

Authors:  L Keilholz; M H Seegenschmiedt; A D Born; R Sauer
Journal:  Strahlenther Onkol       Date:  1997-01       Impact factor: 3.621

2.  Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years.

Authors:  Nicolas Betz; Oliver J Ott; Boris Adamietz; Rolf Sauer; Rainer Fietkau; Ludwig Keilholz
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

Review 3.  Systematic review of non-surgical treatments for early dupuytren's disease.

Authors:  Catherine Ball; David Izadi; Liaquat Suleman Verjee; James Chan; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2016-08-15       Impact factor: 2.362

4.  Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study.

Authors:  Jagdeep Nanchahal; Catherine Ball; Jennifer Swettenham; Susan Dutton; Vicki Barber; Joanna Black; Bethan Copsey; Melina Dritsaki; Peter Taylor; Alastair Gray; Marc Feldmann; Sarah Lamb
Journal:  Wellcome Open Res       Date:  2017-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.